Search Results - "Gore, Elizabeth"

Prophylactic cranial irradiation for patients with lung cancer by Péchoux, Cécile Le, Dr, Sun, Alexander, MD, Slotman, Ben J, Prof, De Ruysscher, Dirk, Prof, Belderbos, José, MD, Gore, Elizabeth M, Prof

“…Summary The incidence of brain metastases in patients with lung cancer has increased as a result of improved local and systemic control and better diagnosis…”
Get full text

Select Patients With “Limited” Extensive-Stage Small Cell Lung Cancer Should Be Treated Aggressively by Gore, Elizabeth M.

Get full text

Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With Chemoradiation: An Analysis of the Radiation Therapy Oncology Group by Machtay, Mitchell, M.D, Bae, Kyounghwa, Ph.D, Movsas, Benjamin, M.D, Paulus, Rebecca, B.S, Gore, Elizabeth M., M.D, Komaki, Ritsuko, M.D, Albain, Kathy, M.D, Sause, William T., M.D, Curran, Walter J., M.D

“…Purpose Patients treated with chemoradiotherapy for locally advanced non–small-cell lung carcinoma (LA-NSCLC) were analyzed for local-regional failure (LRF)…”
Get full text

Decline in Tested and Self-Reported Cognitive Functioning After Prophylactic Cranial Irradiation for Lung Cancer: Pooled Secondary Analysis of Radiation Therapy Oncology Group Randomized Trials 0212 and 0214 by Gondi, Vinai, MD, Paulus, Rebecca, MS, Bruner, Deborah W., RN, PhD, FAAN, Meyers, Christina A., PhD, Gore, Elizabeth M., MD, Wolfson, Aaron, MD, Werner-Wasik, Maria, MD, Sun, Alexander Y., MD, PhD, Choy, Hak, MD, Movsas, Benjamin, MD

“…Purpose To assess the impact of prophylactic cranial irradiation (PCI) on self-reported cognitive functioning (SRCF), a functional scale on the European…”
Get full text

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial by Roach, Mack, Moughan, Jennifer, Lawton, Colleen A F, Dicker, Adam P, Zeitzer, Kenneth L, Gore, Elizabeth M, Kwok, Young, Seider, Michael J, Hsu, I-Chow, Hartford, Alan C, Horwitz, Eric M, Yamoah, Kosj, Jones, Christopher U, Michalski, Jeff M, Lee, W Robert, Pisansky, Thomas M, Rabinovitch, Rachel, Rotman, Marvin, Pryzant, Rodger M, Kim, Harold E, Thomas, Charles R, Shipley, William U, Sandler, Howard M

“…The NRG/RTOG 9413 study showed that whole pelvic radiotherapy (WPRT) plus neoadjuvant hormonal therapy (NHT) improved progression-free survival in patients…”
Get full text

Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data by Santana-Davila, Rafael, Devisetty, Kiran, Szabo, Aniko, Sparapani, Rodney, Arce-Lara, Carlos, Gore, Elizabeth M, Moran, Amy, Williams, Christina D, Kelley, Michael J, Whittle, Jeffrey

“…The optimal chemotherapy regimen to use with radiotherapy in stage III non-small-cell lung cancer is unknown. Here, we compare the outcome of patents treated…”
Get full text

Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214 by GORE, Elizabeth M, BAE, Kyounghwa, WONG, Stuart J, SUN, Alexander, BONNER, James A, SCHILD, Steven E, GASPAR, Laurie E, BOGART, Jeffery A, WERNER-WASIK, Maria, CHOY, Hak

“…This study was conducted to determine if prophylactic cranial irradiation (PCI) improves survival in locally advanced non-small-cell lung cancer (LA-NSCLC)…”
Get full text

Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937 by Gore, Elizabeth M, Hu, Chen, Sun, Alexander Y, Grimm, Daniel F, Ramalingam, Suresh S, Dunlap, Neal E, Higgins, Kristin A, Werner-Wasik, Maria, Allen, Aaron M, Iyengar, Puneeth, Videtic, Gregory M M, Hales, Russell K, McGarry, Ronald C, Urbanic, James J, Pu, Anthony T, Johnstone, Candice A, Stieber, Volker W, Paulus, Rebecca, Bradley, Jeffrey D

“…NRG Oncology RTOG 0937 is a randomized phase II trial evaluating 1-year overall survival (OS) with prophylactic cranial irradiation (PCI) or PCI plus…”
Get more information

Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analysis by SUN, Alexander, BAE, Kyounghwa, WERNER- WASIK, Maria, CHOY, Hak, GORE, Elizabeth M, MOVSAS, Benjamin, WONG, Stuart J, MEYERS, Christina A, BONNER, James A, SCHILD, Steven E, GASPAR, Laurie E, BOGART, Jeffery A

“…There are scant data regarding the effects of prophylactic cranial irradiation (PCI) on neurocognitive function (NCF) and quality of life (QOL). Radiation…”
Get full text

Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910 by Pisansky, Thomas M, Hunt, Daniel, Gomella, Leonard G, Amin, Mahul B, Balogh, Alexander G, Chinn, Daniel M, Seider, Michael J, Duclos, Marie, Rosenthal, Seth A, Bauman, Glenn S, Gore, Elizabeth M, Rotman, Marvin Z, Lukka, Himanshu R, Shipley, William U, Dignam, James J, Sandler, Howard M

“…To determine whether prolonged androgen suppression (AS) duration before radiotherapy improves survival and disease control in prostate cancer. One thousand…”
Get full text

In vitro and in vivo induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor by Gilmartin, Aidan G, Groy, Arthur, Gore, Elizabeth R, Atkins, Charity, Long, Edward R, Montoute, Monica N, Wu, Zining, Halsey, Wendy, McNulty, Dean E, Ennulat, Daniela, Rueda, Lourdes, Pappalardi, Melissa, Kruger, Ryan G, McCabe, Michael T, Raoof, Ali, Butlin, Roger, Stowell, Alexandra, Cockerill, Mark, Waddell, Ian, Ogilvie, Donald, Luengo, Juan, Jordan, Allan, Benowitz, Andrew B

“…Pharmacological induction of fetal hemoglobin (HbF) expression is an effective therapeutic strategy for the management of beta-hemoglobinopathies such as…”
Get full text

Limited‐Stage Small Cell Lung Cancer: Current Chemoradiotherapy Treatment Paradigms by Stinchcombe, Thomas E., Gore, Elizabeth M.

“…In the U.S., the prevalence of small cell lung cancer (SCLC) is declining, probably reflecting the decreasing prevalence of tobacco use. However, a significant…”
Get full text

Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy by Simone, 2nd, Charles B, Serebrenik, Artur A, Gore, Elizabeth M, Mohindra, Pranshu, Brown, Stephen L, Wang, Ding, Chetty, Indrin J, Vujaskovic, Zeljko, Menon, Smitha, Thompson, Jonathan, Fine, Gil, Kaytor, Michael D, Movsas, Benjamin

“…Radiation therapy is part of the standard treatment regimen for non-small cell lung cancer (NSCLC). Although radiation therapy is an effective tool to manage…”
Get full text

Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline by Simone, Charles B., Bogart, Jeffrey A., Cabrera, Alvin R., Daly, Megan E., DeNunzio, Nicholas J., Detterbeck, Frank, Faivre-Finn, Corinne, Gatschet, Nancy, Gore, Elizabeth, Jabbour, Salma K., Kruser, Tim J., Schneider, Bryan J., Slotman, Ben, Turrisi, Andrew, Wu, Abraham J., Zeng, Jing, Rosenzweig, Kenneth E.

“…Several sentinel phase III randomized trials have recently been published challenging traditional radiation therapy (RT) practices for small cell lung cancer…”
Get full text

Decreased Risk of Radiation Pneumonitis With Incidental Concurrent Use of Angiotensin-Converting Enzyme Inhibitors and Thoracic Radiation Therapy by Kharofa, Jordan, M.D, Cohen, Eric P., M.D, Tomic, Rade, M.D, Xiang, Qun, M.S, Gore, Elizabeth, M.D

“…Purpose Angiotensin-converting enzyme (ACE) inhibitors have been shown to mitigate radiation-induced lung injury in preclinical models. The aim of this study…”
Get full text

Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial by Spratt, Daniel E., Liu, Vinnie Y.T., Michalski, Jeff, Davicioni, Elai, Berlin, Alejandro, Simko, Jeffry P., Efstathiou, Jason A., Tran, Phuoc T., Sandler, Howard M., Hall, William A., Thompson, Darby J.S., Parliament, Matthew B., Dayes, Ian S., Correa, Rohann Jonathan Mark, Robertson, John M., Gore, Elizabeth M., Doncals, Desiree E., Vigneault, Eric, Souhami, Luis, Karrison, Theodore G., Feng, Felix Y.

“…Intermediate-risk prostate cancer is a heterogeneous disease state with diverse treatment options. The 22-gene Decipher genomic classifier (GC) retrospectively…”
Get full text

Technical Note: Is bulk electron density assignment appropriate for MRI‐only based treatment planning for lung cancer? by Prior, Phil, Chen, Xinfeng, Gore, Elizabeth, Johnstone, Candice, Li, X. Allen

“…Purpose MRI‐based treatment planning in radiation therapy (RT) is prohibitive, in part, due to the lack of electron density (ED) information within the image…”
Get full text

Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial by Mell, Loren K., Pugh, Stephanie L., Jones, Christopher U., Nelson, Tyler J., Zakeri, Kaveh, Rose, Brent S., Zeitzer, Kenneth L., Gore, Elizabeth M., Bahary, Jean-Paul, Souhami, Luis, Michalski, Jeff M., Hartford, Alan C., Mishra, Mark V., Roach, Mack, Parliament, Matthew B., Choi, Kwang N., Pisansky, Thomas M., Husain, Siraj M., Malone, Shawn C., Horwitz, Eric M., Feng, Felix

“…We used a novel method (omega score) to analyse the effects of short-term androgen deprivation therapy (ADT) for prostate cancer according to the relative risk…”
Get full text

Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer by Borkenhagen, Jenna F., Bergom, Carmen, Rapp, Cooper T., Klawikowski, Slade J., Rein, Lisa E., Gore, Elizabeth M.

“…Higher cardiac radiotherapy (RT) doses when treating lung cancer are associated with worse overall survival (OS), although the direct association between…”
Get full text

Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery by Kachnic, Lisa A., Winter, Kathryn, Suntharalingam, Mohan, Ilson, David, Konski, André, Lloyd, Shane, McAvoy, Sarah A., Lad, Thomas, Olowokure, Olugbenga Gbenga, Samson, Pamela, Gore, Elizabeth M., Meyer, Joshua E., Videtic, Gregory M. M., Clump, David A., Raben, Adam, Kayaleh, Omar, Barker, Jerry, Haddock, Michael G., Hopkins, Judith O., Bruner, Deborah W.

“…Purpose/objectives NRG/RTOG 0436 evaluated cetuximab added to chemoradiation (CRT) for non-operative esophageal cancer management. PRO objectives assessed…”
Get full text